25 results on '"Raynaud, F"'
Search Results
2. Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
3. 705 Clinical and Economic Impact of a Partially Hydrolyzed Formula in the Prevention of Atopic Dermatitis in French Children
4. 706 Clinical and Economic Impact of a Partially Hydrolyzed Formula in the Prevention of Atopic Dermatitis in Spanish Children
5. A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy
6. Modeling collective motion: variations on the Vicsek model
7. A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
8. A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies
9. A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points
10. Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026
11. Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice
12. Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer
13. A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)
14. A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalation
15. Postmortem Degradation of White Fish Skeletal Muscle (Sea Bass, Dicentrarchus labrax): Fat Diet Effects on In Situ Dystrophin Proteolysis During the Prerigor Stage
16. Phase I study of oral JM216 given twice daily
17. Phase I trial and pharmacokinetics of the tubulin inhibitor 1069C85--a synthetic agent binding at the colchicine site designed to overcome multidrug resistance
18. Biotransformation of the platinum drug JM216 following oral administration to cancer patients
19. Preclinical pharmacology of 1069C85, a novel tubulin binder
20. Effect of different photoperiods on the diurnal rhythm of 5-methoxytryptamine in the pineal gland of golden hamsters (Mesocricetus auratus)
21. Plasma concentrations of 5-methoxytryptamine, 5-methoxytryptophol and melatonin after 5-methoxytryptamine administration of golden hamsters: physiological implications
22. EVALUATION OF GROWTH HORMONE (GH) SECRETION IN SHORT CHILDREN: SLEEP SECRETION AND STIMULATION TESTS
23. Tissue histamine levels and mast cell numbers in tumour-bearing mice
24. Comparison of growth hormone (GH) sleep secretion and responses to pharmacological tests
25. Treatment of male and female precocious puberty (PP) by monthly injections of a continuous release preparation of D-Trp-6-LH-RH
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.